RxDoctor Payments Data

Charissa Parker

Nurse Practitioner · Dallas, TXNPI 1225503394

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,523 of the $8,665 with a category attached, or 86.8%. It is spread thinly across 55 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,526 and has fallen 82.2% since, to $449 in 2025. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,665in general payments, 2019–2025

Across 276 payments — averaging $31.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceutical Holding Company Ltd.$1K
  • Amgen$975
  • AbbVie$509
  • Otsuka America Pharmaceutical, Inc.$482
  • AstraZeneca$440
  • Sanofi$333
  • plus $5K from 49 others

What the payments were for

  • Consulting fees$8009%
  • Travel & lodging$3414%
  • Food & beverage$7,52387%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,665 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas →

Medicare billing

Part B allowed, 2024
$3,877
Medicare patients
25
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cinacalcet Hcl18$2,965
Atorvastatin Calcium43$287
Nifedipine ErNifedipine15$257
Alendronate Sodium26$204
Prednisone26$170
Losartan Potassium25$141
Carvedilol11$93
Hydralazine Hcl11$78
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$40

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →